352 related articles for article (PubMed ID: 2450281)
1. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.
Patarroyo ME; Amador R; Clavijo P; Moreno A; Guzman F; Romero P; Tascon R; Franco A; Murillo LA; Ponton G
Nature; 1988 Mar; 332(6160):158-61. PubMed ID: 2450281
[TBL] [Abstract][Full Text] [Related]
2. Induction of protective immunity against experimental infection with malaria using synthetic peptides.
Patarroyo ME; Romero P; Torres ML; Clavijo P; Moreno A; Martínez A; Rodríguez R; Guzman F; Cabezas E
Nature; 1987 Aug 13-19; 328(6131):629-32. PubMed ID: 3302727
[TBL] [Abstract][Full Text] [Related]
3. A recombinant hybrid protein as antigen for an anti-blood stage malaria vaccine.
Knapp B; Hundt E; Enders B; Küpper HA
Behring Inst Mitt; 1991 Feb; (88):147-56. PubMed ID: 2049032
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
Xu L; Pei X; Berzins K; Chaudhuri A
Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
[TBL] [Abstract][Full Text] [Related]
6. Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens.
Quakyi IA; Otoo LN; Pombo D; Sugars LY; Menon A; De Groot AS; Johnson A; Alling D; Miller LH; Good MF
Am J Trop Med Hyg; 1989 Aug; 41(2):125-34. PubMed ID: 2672834
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.
Herrington DA; Clyde DF; Losonsky G; Cortesia M; Murphy JR; Davis J; Baqar S; Felix AM; Heimer EP; Gillessen D
Nature; 1987 Jul 16-22; 328(6127):257-9. PubMed ID: 2439920
[TBL] [Abstract][Full Text] [Related]
9. A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies.
Theisen M; Soe S; Brunstedt K; Follmann F; Bredmose L; Israelsen H; Madsen SM; Druilhe P
Vaccine; 2004 Mar; 22(9-10):1188-98. PubMed ID: 15003647
[TBL] [Abstract][Full Text] [Related]
10. Potential vaccine antigens of the asexual blood-stages of Plasmodium falciparum.
Anders RF; Brown GV; Coppel RL; Stahl HD; Bianco AE; Favaloro JM; Crewther PE; Culvenor JG; Kemp DJ
Dev Biol Stand; 1985; 62():81-9. PubMed ID: 2422079
[TBL] [Abstract][Full Text] [Related]
11. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.
Patarroyo ME; Patarroyo MA
Acc Chem Res; 2008 Mar; 41(3):377-86. PubMed ID: 18266328
[TBL] [Abstract][Full Text] [Related]
12. Protection against Plasmodium falciparum challenge induced in Aotus monkeys by liver-stage antigen-3-derived long synthetic peptides.
Perlaza BL; Valencia AZ; Zapata C; Castellanos A; Sauzet JP; Blanc C; Cohen J; Arévalo-Herrera M; Corradin G; Herrera S; Druilhe P
Eur J Immunol; 2008 Sep; 38(9):2610-5. PubMed ID: 18792413
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to a Plasmodium falciparum blood-stage antigen as a tool for predicting the protection levels of two malaria-exposed populations.
Astagneau P; Roberts JM; Steketee RW; Wirima JJ; Lepers JP; Deloron P
Am J Trop Med Hyg; 1995 Jul; 53(1):23-8. PubMed ID: 7542843
[TBL] [Abstract][Full Text] [Related]
14. Malaria vaccine.
Khurana SK; Talib VH
Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
[TBL] [Abstract][Full Text] [Related]
15. Tandem use of PCR and synthetic peptides to map helper T-cell epitopes on 27-kDa sexual stage antigen of Plasmodium falciparum.
Koski GK; Ploton IN; Viscidi R; Kumar N
Pept Res; 1996; 9(3):127-35. PubMed ID: 8875592
[TBL] [Abstract][Full Text] [Related]
16. Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum.
Collins WE; Anders RF; Pappaioanou M; Campbell GH; Brown GV; Kemp DJ; Coppel RL; Skinner JC; Andrysiak PM; Favaloro JM
Nature; 1986 Sep 18-24; 323(6085):259-62. PubMed ID: 2429187
[TBL] [Abstract][Full Text] [Related]
17. Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization.
Bermúdez A; Reyes C; Guzmán F; Vanegas M; Rosas J; Amador R; Rodríguez R; Patarroyo MA; Patarroyo ME
Vaccine; 2007 May; 25(22):4487-501. PubMed ID: 17403557
[TBL] [Abstract][Full Text] [Related]
18. Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
Polhemus ME; Magill AJ; Cummings JF; Kester KE; Ockenhouse CF; Lanar DE; Dutta S; Barbosa A; Soisson L; Diggs CL; Robinson SA; Haynes JD; Stewart VA; Ware LA; Brando C; Krzych U; Bowden RA; Cohen JD; Dubois MC; Ofori-Anyinam O; De-Kock E; Ballou WR; Heppner DG
Vaccine; 2007 May; 25(21):4203-12. PubMed ID: 17442466
[TBL] [Abstract][Full Text] [Related]
19. Towards a malaria vaccine: what is in sight?
del Giudice G
Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171
[No Abstract] [Full Text] [Related]
20. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
Dobaño C; Doolan DL
Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
